Ligand Pharmaceuticals Inc (LGND)

Sales/Maturities of Investments

$361.72M

Quarterly · Period ending: · USD

LGND logo

LGND Sales/Maturities of Investments

Latest reported$361.72M
LGND Quarterly Sales/Maturities of Investments ($5.60M → $361.72M)
High-resolution chart · PNG

LGND sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
361,718,000
120,650,000
202,180,000
53,470,000
50,860,000
70,774,000
45,184,000
94,795,000
47,056,000
75,463,000
59,908,000
24,761,000
56,801,000
52,697,000
7,009,000
24,998,000
44,688,000
157,696,000
31,770,000
4,317,000
44,341,000
140,907,000
60,243,000
346,615,000
0
476,436,000
611,695,000
584,303,000
501,742,000
332,988,000
567,132,000
334,717,000
56,350,000
66,616,000
37,357,000
24,122,000
87,384,000
47,771,000
6,389,000
31,481,000
36,929,000
68,671,000
44,626,000
26,269,000
1,919,000
459,000
846,000
340,000
530,000
626,000
0
0
0
0
0
1,500,000
0
8,500,000
0
0
5,458,000
13,888,000
2,734,000
10,639,000
5,924,000
34,743,000
2,001,000
13,044,000
17,316,000
15,400,000
12,752,000
-101,000
10,352,000
9,012,000
12,134,000
-237,000
1,091,000
7,128,000
8,591,000
2,778,000
6,301,000
7,884,000
6,575,000
15,065,000
6,738,000
2,945,000
22,431,000
9,892,000
548,000
16,797,000
760,000
4,289,000
3,781,000
1,223,000
3,450,000
12,112,000
1,901,000
591,000
6,743,000
765,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.